Name | APTEKA N183, OAO |
|---|
INN | 6603022372 |
|---|
KPP | 660301001 |
|---|
OGRN | 1096603000240 |
|---|
OKPO | 1904910 |
|---|
FFSM | 33335-D |
|---|
Address | 624262, Sverdlovskaya Oblast', g. Asbest, ul. Chelyuskintsev, d. D.17/1 |
|---|
Phone | +7 (343) 652-39-73 Contact details |
|---|
Fax | +7 (343) 652-87-70 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores |
Registration date | 04.03.2009 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po g.Asbestu Sverdlovskoy oblasti |
|---|
|
APTEKA N183, OAO (Sverdlovsk Oblast; INN 6603022372) was registered on 4 Mar 2009. The company's authorized capital as of July 1, 2012 was 2789000 rub. Type of ownership of APTEKA N183, OAO - Open joint-stock companies. Form of ownership of APTEKA N183, OAO - Municipal property. Principal activities of APTEKA N183, OAO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2022
Net profit (RAS) of APTEKA N183, OAO grew over 2022 by 4.44% to 47.00 thousand RUB from 45.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 3.08% to 60.04 million RUB from 58.25 million RUB over 2021; cost of goods sold grew by 2.67% to 45.51 million RUB from 44.33 million RUB; sales profit fell by 24.13% to 720.00 thousand RUB from 949.00 thousand RUB. 2021
Net profit (RAS) of APTEKA N183, OAO over 2021 was the same as in 2020 reaching 45.00 thousand RUB, the company informed. Revenue decreased in the accounting period by 1.06% to 58.25 million RUB from 58.87 million RUB in 2020; cost of goods sold decreased by 1.27% to 44.33 million RUB from 44.90 million RUB; sales profit went up by 4.29% to 949.00 thousand RUB from 910.00 thousand RUB. 2020
Net profit (RAS) of APTEKA N183, OAO over 2020 was the same as in 2019 reaching 45.00 thousand RUB, the company informed. Revenue decreased in the accounting period by 3.69% to 58.87 million RUB from 61.12 million RUB in 2019; cost of goods sold decreased by 2.26% to 44.90 million RUB from 45.94 million RUB; sales profit went up by 9.38% to 910.00 thousand RUB from 832.00 thousand RUB. 2019
Net profit (RAS) of APTEKA N183, OAO grew over 2019 by 2.27% to 45.00 thousand RUB from 44.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 3.18% to 61.12 million RUB from 59.24 million RUB over 2018; cost of goods sold grew by 3.32% to 45.94 million RUB from 44.46 million RUB; sales profit fell by 8.47% to 832.00 thousand RUB from 909.00 thousand RUB. 2018
Net profit (RAS) of APTEKA N183, OAO grew over 2018 by 4.76% to 44.00 thousand RUB from 42.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 3.45% to 59.24 million RUB from 57.27 million RUB over 2017; cost of goods sold grew by 3.14% to 44.46 million RUB from 43.11 million RUB; sales profit went up by 0.66% to 909.00 thousand RUB from 903.00 thousand RUB. 2017
Net profit (RAS) of APTEKA N183, OAO grew over 2017 by 5.00% to 42.00 thousand RUB from 40.00 thousand RUB over 2016, the company informed. Revenue decreased in the accounting period by 3.34% to 57.27 million RUB from 59.25 million RUB in 2016; cost of goods sold decreased by 4.29% to 43.11 million RUB from 45.04 million RUB; sales profit fell by 3.01% to 903.00 thousand RUB from 931.00 thousand RUB. 2016
Net profit (RAS) of APTEKA N183, OAO grew over 2016 2.86 times to 40.00 thousand RUB from 14.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period by 16.66% to 59.25 million RUB from 50.79 million RUB over 2015; cost of goods sold grew by 15.07% to 45.04 million RUB from 39.14 million RUB; sales profit went up by 32.62% to 931.00 thousand RUB from 702.00 thousand RUB. 2014
Net profit (RAS) of Apteka N 183, OAO dropped in 2014 by 24.46% to 488.00 thousand RUB from 646.00 thousand RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 6.93% to 52.07 million RUB from 48.69 million RUB over 2013; cost of goods sold grew by 8.74% to 40.24 million RUB from 37.00 million RUB; sales profit fell by 6.04% to 1.14 million RUB from 1.21 million RUB. 2013
Net profit (RAS) of Apteka N 183, OAO grew over 2013 1.60 times to 646.00 thousand RUB from 405.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 3.64% to 48.69 million RUB from 46.98 million RUB over 2012; cost of goods sold grew by 4.45% to 37.00 million RUB from 35.43 million RUB; sales profit went up by 34.37% to 1.21 million RUB from 899.00 thousand RUB. 2012
Net profit (RAS) of Apteka N 183, OAO grew over 2012 3.12 times to 405.00 thousand RUB from 130.00 thousand RUB over 2011, the company informed. Cost of goods sold grew by 10.92% to 35.43 million RUB from 31.94 million RUB; sales profit went up 1.86 times to 899.00 thousand RUB from 484.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|